Inebilizumab for Treatment of IgG4-Related Disease
Amgen
John H Stone; Arezou Khosroshahi; Wen Zhang; Emanuel Della Torre; Kazuichi Okazaki; Yoshiya Tanaka; J Matthias Löhr; Nicolas Schleinitz; Lingli Dong; Hisanori Umehara; Marco Lanzillotta; Zachary S Wallace; Mikael Ebbo; George J Webster; Fernando Martinez Valle; Manu K Nayar; Cory A Perugino; Vinciane Rebours; Xinxin Dong; Yanping Wu; Qing Li; Nishi Rampal; Daniel Cimbora; Emma L Culver; MITIGATE Trial Investigators